MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 100 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,350,000 | -37.5% | 925,382 | -50.0% | 0.19% | -14.9% |
| Q1 2020 | $3,758,000 | +88.0% | 1,850,764 | +100.0% | 0.22% | -3.5% |
| Q4 2019 | $1,999,000 | +17.9% | 925,382 | -15.9% | 0.23% | +21.8% |
| Q3 2019 | $1,695,000 | -70.8% | 1,100,000 | -21.4% | 0.19% | -64.5% |
| Q2 2019 | $5,811,000 | -0.7% | 1,400,000 | 0.0% | 0.53% | -0.4% |
| Q1 2019 | $5,852,000 | +51.0% | 1,400,000 | +3.7% | 0.53% | +126.0% |
| Q4 2018 | $3,875,000 | -64.8% | 1,350,000 | +22.7% | 0.24% | -67.1% |
| Q3 2018 | $11,000,000 | +29.7% | 1,100,000 | -8.3% | 0.71% | +24.6% |
| Q2 2018 | $8,484,000 | +85.1% | 1,200,000 | 0.0% | 0.57% | +41.5% |
| Q1 2018 | $4,584,000 | +2.1% | 1,200,000 | +118.2% | 0.40% | +7.1% |
| Q4 2017 | $4,488,000 | – | 550,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |